Results 31 to 40 of about 25,279 (271)
“Atypical” atypical parkinsonism: Critical appraisal of a cohort [PDF]
Parkinsonism & Related Disorders, 2017 Atypical parkinsonian conditions such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal syndrome (CBS) and Dementia with Lewy bodies (DLB) comprise 10-15% of parkinsonian syndromes. Misdiagnosis with Parkinson disease (PD) and within the entities is common, given the absence of reliable biomarkers.
Hirschbichler, Stephanie T. +6 more
openaire +5 more sources
First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
npj Parkinson's Disease, 2021 To define the incidence, predictors and prognosis of the first hospital delirium episode in Parkinson’s disease (PD) and atypical parkinsonism (AP), we identified the first hospital episode of delirium after diagnosis in the Parkinsonism Incidence in ...
Samantha Green +6 more
doaj +1 more source
Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study
Frontiers in Aging Neuroscience, 2022 BackgroundParkinsonian syndromes may rarely occur in motor neuron disease (MND). However, previous studies are heterogeneous and mostly case reports or small case series.
Jacopo Pasquini +17 more
doaj +1 more source
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008 The dopamine deficiency syndrome Parkinson's disease (PD) is characterized by tremor, rigidity, bradykinesia and reduced postural reflexes. Conditions with similar symptoms but other causes than PD (about 1/3 of cases) are called atypical parkinsonism.
Mark Edwards +2 more
openaire +3 more sources
Ankylosing Spondylitis: A Risk Factor for Parkinsonism—A Nationwide Population-Based Study
Journal of Parkinson’s Disease, 2022 Background: Ankylosing spondylitis (AS) is an immune-mediated, chronic inflammatory rheumatic disorder. The etiology of Parkinson’s disease (PD) is multifactorial; however, inflammation is receiving an increasing amount of attention as an underlying ...
Seo Yeon Yoon +4 more
doaj +1 more source
Mortality in Parkinson's disease : A systematic review and meta-analysis [PDF]
, 2014 © 2014 International Parkinson and Movement Disorder Society.Peer reviewedPublisher ...
Greenland S +3 more
core +1 more source
Atypical Ubiquitination and Parkinson’s Disease
International Journal of Molecular Sciences, 2022 Ubiquitination (the covalent attachment of ubiquitin molecules to target proteins) is one of the main post-translational modifications of proteins. Historically, the type of polyubiquitination, which involves K48 lysine residues of the monomeric ubiquitin, was the first studied type of ubiquitination.
Buneeva, Olga, Medvedev, Alexei
openaire +2 more sources
Rest tremor in Parkinson's disease: body distribution and time of appearance [PDF]
, 2017 Objective To assess body distribution and timing of appearance of rest tremor in Parkinson's disease. Methods Information was obtained by a computerized database containing historical information collected at the first visit and data collected during the
Custodero, Giacomo Emanuele +8 more
core +1 more source
Multi-modal rehabilitation therapy in Parkinson's disease and related disorders
Annals of Indian Academy of Neurology, 2023 Long-term use of dopaminergic therapy in Parkinson's disease (PD) is associated with reduction in efficacy and disabling dyskinesias. The current medical or surgical treatment modalities are ineffective for atypical parkinsonism syndromes.
Alvee Saluja +2 more
doaj +1 more source
Metoclopramide Neurological Side Effects Screening; A Pharmacovigilence Study in Romanian Community Pharmacies [PDF]
, 2015 Background. Metoclopramide is a pharmacological agent frequently used in therapy against nausea and vomiting that can occur in indigestion, motion sickness, gastric ulcer, pyloric spasm and after surgery as a side effect of some anesthetics.
Junghină, Adrian +4 more
core +4 more sources